Intra-Operative Metrics With CENTURION and INFINITI Vision Systems
Status: | Completed |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 55 - Any |
Updated: | 3/1/2014 |
Start Date: | July 2013 |
End Date: | January 2014 |
Contact: | Alcon Call Center |
Email: | alcon.medinfo@alcon.com |
Phone: | 1-888-451-3937 |
Intra-Operative Metrics and Clinical Outcomes After Cataract Surgery With the CENTURION Vision System and the INFINITI Vision System
The purpose of this study is to determine if intra-operative phacoemulsification machine
metrics are lower after phacoemulsification with the CENTURION vision system compared with
the INFINITI vision system.
metrics are lower after phacoemulsification with the CENTURION vision system compared with
the INFINITI vision system.
Inclusion Criteria:
- Eligible to undergo cataract extraction via phacoemulsification with primary ACRYSOF
Intraocular Lens (IOL) implantation;
- Free of severe disease(s)/condition(s) listed in the "Warnings" and "Precautions"
section of implanted ACRYSOF IOL;
- Willing to undergo second eye surgery within 14 days of first eye surgery;
- Willing and able to understand/sign a written Informed Consent Document;
- Willing and able to return for scheduled follow-up examinations;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Planned multiple procedures at the time of surgery or during the course of the study
(eg, LASIK, LRI, etc.);
- Previous intraocular or corneal surgery of any kind;
- Poorly dilating pupil;
- Severe retinal disorders (eg, macular degeneration, proliferative diabetic
retinopathy);
- Corneal disease (eg, herpes simplex, herpes zoster, etc) or retinal detachment;
- Severe conditions that per Investigator's clinical judgment would increase the
operative risk or confound the result of this investigation;
- Female patients who are pregnant, lactating, or planning to be pregnant during the
course of the study;
- Currently participating in another drug or device clinical trial, or participated in
another drug or device clinical trial within 30 days of enrollment into this trial;
- Other protocol-defined exclusion criteria may apply.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials